Chemical cardioversion of recent-onset atrial fibrillation in the emergency department using vernakalant hydrochloride achieves safe and rapid restoration of sinus rhythm and facilitates same day discharge
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
http://link.springer.com/article/10.1007/s11845-017-1576-1/fulltext.html
Reference25 articles.
1. Lip G, Tse H, Lane D (2012) Atrial fibrillation. Lancet 379(9816):648–661
2. Feinberg WM, Blackshear J, Laupacis A et al (1995) Prevalence, age distribution and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 155:469–473
3. Weigner MJ, Caulfield TA, Danias PG et al (1997) Risk for clinical thromboembolism associated with conversion to sinus rhythm in patients with atrial fibrillation lasting less than 48 hours. Ann Intern Med 126:615–620
4. Lafuente-Lafuente C, Mouly S, Longás-Tejero M et al (2006) Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation. Arch Intern Med 166(7):719–728
5. Freemantle N, Lafuente-Lafuente C, Mitchell S et al (2011) Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. Europace 13(3):329–345
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Vernakalant for Cardioversion of Recent-Onset Atrial Fibrillation in the Emergency Department: The SPECTRUM Study;Cardiology;2022
2. A rare case of vernakalant-induced 1:1 atrial flutter during chemical cardioversion of atrial fibrillation requiring emergency direct current cardioversion;British Journal of Cardiac Nursing;2021-06-02
3. Does the choice of drug in pharmacologic cardioversion correlate with the guidelines? Systematic review;Advances in Clinical and Experimental Medicine;2021-03-23
4. Vernakalant for Rapid Cardioversion of Recent-Onset Atrial Fibrillation: Results from the SPECTRUM Study;Cardiovascular Drugs and Therapy;2020-11-18
5. Vernakalant hydrochloride for the treatment of atrial fibrillation: evaluation of its place in clinical practice;Future Cardiology;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3